MAREA
Live / Applied — Third extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 15 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97720051
- Mark type
- Stylized text
- Filed
- 15 Dec 2022
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations for treating cardiometabolic diseases and disorders administered through subcutaneous injection; chemical and biochemical preparations and substances for medical purposes for treatment of cardiometabolic diseases and disorders; biological preparations for the treatment of cardiometabolic diseases and disorders; chemical and biochemical preparations for medical purposes for use in targeting adipose tissue; prescription pharmaceutical preparations for use in targeting adipose tissue administered through subcutaneous injection; biological preparations for use in targeting adipose tissue; none of the foregoing including dietary and nutritional supplements; none of the foregoing including over-the-counter medicines
- Class 040 — Treatment of materials: Custom manufacture of prescription pharmaceutical preparations; manufacturing services for others in the field of prescription pharmaceutical products; none of the foregoing including manufacture of dietary and nutritional supplements; none of the foregoing including manufacture of over-the-counter medicines
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of cardiometabolic diseases and disorders; pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields; none of the foregoing including research and development in the field of dietary and nutritional supplements; none of the foregoing including research and development in the field of over-the-counter medicines
Owner
- MAREA THERAPEUTICS, INC., SAN FRANCISCO, CA, US
- MAREA THERAPEUTICS, INC., SAN FRANCISCO, CA, US
- Metabolic Flux NewCo, Inc., Boston, MA, US
Prosecution history
- 28 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 3 GRANTED
- 27 Jan 2026 — SOU EXTENSION 3 FILED
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2025 — SOU EXTENSION 2 GRANTED
- 15 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2025 — SOU EXTENSION 1 GRANTED
- 27 Jan 2025 — SOU EXTENSION 1 FILED
- 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED